CTC Netherlands is a clinical research unit for early phase patient studies and healthy volunteer studies with invasive procedures.

Our unit has 12 beds and is located on the campus of the academic hospital in Groningen, The Netherlands. The proximity to UMCG enables access to the hospital’s specialists and state-of-the-art research facilities, as well as access to trial patients with various indications.
The combination of a small dedicated team of experts, an innovative environment and state-of-the-art facilities enables CTC Netherlands to effectively address the specific needs of early phase patient studies, offering comprehensive support for our clients.

CTC Netherlands is part of the “Center for Translational Research”, a group of complementary life science service companies, including “CTC Clinical Trials Consultants AB”, headquartered in Uppsala, Sweden.

Timeline

CTC Netherlands has been established in February 2024. We are currently in the start-up phase and will be fully operational by mid-April 2024.